- Home
- LRMR vs NB Comparison
LRMR vs NB Comparison
Compare LRMR & NB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LRMR
- NB
- Stock Information
- Founded
- LRMR N/A
- NB 1987
- Country
- LRMR United States
- NB United States
- Employees
- LRMR N/A
- NB N/A
- Industry
- LRMR Biotechnology: Pharmaceutical Preparations
- NB Metal Mining
- Sector
- LRMR Health Care
- NB Basic Materials
- Exchange
- LRMR Nasdaq
- NB Nasdaq
- Market Cap
- LRMR 171.6M
- NB 139.3M
- IPO Year
- LRMR N/A
- NB N/A
- Fundamental
- Price
- LRMR $2.67
- NB $2.60
- Analyst Decision
- LRMR Strong Buy
- NB Strong Buy
- Analyst Count
- LRMR 7
- NB 2
- Target Price
- LRMR $18.86
- NB $4.13
- AVG Volume (30 Days)
- LRMR 1.1M
- NB 696.1K
- Earning Date
- LRMR 08-06-2025
- NB 05-08-2025
- Dividend Yield
- LRMR N/A
- NB N/A
- EPS Growth
- LRMR N/A
- NB N/A
- EPS
- LRMR N/A
- NB N/A
- Revenue
- LRMR N/A
- NB N/A
- Revenue This Year
- LRMR N/A
- NB N/A
- Revenue Next Year
- LRMR N/A
- NB N/A
- P/E Ratio
- LRMR N/A
- NB N/A
- Revenue Growth
- LRMR N/A
- NB N/A
- 52 Week Low
- LRMR $1.61
- NB $1.27
- 52 Week High
- LRMR $11.20
- NB $4.15
- Technical
- Relative Strength Index (RSI)
- LRMR 56.20
- NB 50.59
- Support Level
- LRMR $2.60
- NB $2.50
- Resistance Level
- LRMR $3.02
- NB $3.10
- Average True Range (ATR)
- LRMR 0.25
- NB 0.18
- MACD
- LRMR 0.01
- NB 0.01
- Stochastic Oscillator
- LRMR 51.35
- NB 32.43
About LRMR Larimar Therapeutics Inc.
Larimar Therapeutics Inc is a clinical-stage biotechnology company focused on developing treatments for patients suffering from complex rare diseases using its novel cell-penetrating peptide (CPP) technology platform. Its lead product candidate, CTI-1601, is a subcutaneously administered, recombinant fusion protein intended to deliver human frataxin (FXN) an essential protein, to the mitochondria of patients with Friedreich's ataxia.
About NB NioCorp Developments Ltd.
NioCorp Developments Ltd is engaged in exploration and development of mineral deposits in North America, specifically, the Elk Creek Niobium/Scandium/Titanium property.